Humacyte, Inc. (HUMA)
0.6852
-0.02
(-2.28%)
USD |
NASDAQ |
Aug 26, 16:00
0.6852
0.00 (0.00%)
After-Hours: 20:00
Humacyte Total Assets (Quarterly) : 138.09M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 138.09M |
| March 31, 2026 | 110.56M |
| December 31, 2025 | 116.37M |
| September 30, 2025 | 91.51M |
| June 30, 2025 | 138.80M |
| March 31, 2025 | 162.55M |
| December 31, 2024 | 137.87M |
| September 30, 2024 | 114.76M |
| June 30, 2024 | 138.28M |
| March 31, 2024 | 161.47M |
| December 31, 2023 | 128.22M |
| September 30, 2023 | 149.38M |
| Date | Value |
|---|---|
| June 30, 2023 | 168.11M |
| March 31, 2023 | 182.98M |
| December 31, 2022 | 204.30M |
| September 30, 2022 | 226.22M |
| June 30, 2022 | 246.36M |
| March 31, 2022 | 264.47M |
| December 31, 2021 | 286.53M |
| September 30, 2021 | 303.36M |
| June 30, 2021 | 100.51M |
| March 31, 2021 | 100.67M |
| December 31, 2020 | 106.69M |
| September 30, 2020 | 101.32M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Amgen, Inc. | 95.64B |
| Altimmune, Inc. | 527.21M |
| Protalix Biotherapeutics, Inc. | 110.34M |
| Taysha Gene Therapies, Inc. | 470.43M |
| Agenus, Inc. | 172.69M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 106.83M |
| Shareholders Equity (Quarterly) | 31.26M |
| Debt to Equity Ratio | 2.117 |
| Current Ratio | 6.207 |
| Net Debt Paydown Yield | 1.48% |